Ikonisys is headquartered in Paris, France.
Ikonisys has 10 employees.
Ikonisys is a life science company.
Ikonisys was founded in 1999.
Ikonisys is a cell-based diagnostics company specializing in the early and accurate detection of cancer. The company develops, produces, and markets the proprietary Ikoniscope20 and Ikoniscope20max platforms, fully automated solutions designed to deliver accurate and reliable detection and analysis of rare and very rare cells. Ikonisys was formed in 1999 and is based in Paris, France.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | - | 1 | - | - | 1 |
| vol | $5M | $5M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
